60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) stock news · rev $1.0M
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) is a biotechnology company listed on NASDAQ.
This SXTPW news page leads with what 60 Degrees Pharmaceuticals, Inc. Warrant filed — not a scraped headline mill.
No cached 8-K sentence for SXTPW yet. We will not pad this page with generic market recap.
Latest reported SXTPW revenue for 2025-12-31 was $1.0M. Net income was -$7.4M. Revenue was up 65.5% from 2024-12-31 to 2025-12-31.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SXTPW stock page; for the tape open the quote page.
SXTPW stock news FAQ
What are SXTPW's latest revenue and net income?
Latest cached 60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) revenue for Dec 31, 2025 was $1.0M. Net income was -$7.4M. Statements: https://lician.com/financials/sxtpw
How did SXTPW revenue change from the prior cached period?
Cached 60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) revenue was up 65.5% from $607.6K (Dec 31, 2024) to $1.0M (Dec 31, 2025). Statements: https://lician.com/financials/sxtpw
What kind of company is SXTPW?
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) is a biotechnology company listed on NASDAQ.
Where is SXTPW stock news listed?
Cached stock news for 60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) is listed at https://lician.com/news/sxtpw. Filings: https://lician.com/sec/sxtpw
Not investment advice.